1,136
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations

, &
Pages 333-341 | Received 30 Jul 2013, Accepted 21 Oct 2013, Published online: 27 Nov 2013

References

  • Remington: the science and practice of pharmacy. Vol. 21. New Delhi: Wolters Kluwer (India) Pvt. Ltd; 2005:889–928
  • Roberts M, Ford JL, MacLeod GS, et al. Effects of surface roughness and chrome plating of punch tips on the sticking tendencies of model ibuprofen formulations. J Pharm Pharmacol 2003;55:1223–8
  • Deutchman AH, Natoli DC. Tableting punch performance can be improved with precision coatings. Beamalloy Technologies LLC [Online]. Available from: http://www.beamalloy.net/client_images/catalog19951/pages/files/Pharmproc902B.pdf [last accessed 12 Nov 2013]
  • Deutchman AH. Choosing coatings to improve the performance of tablet tooling. Tablets Capsules 2004;2:1--7
  • Chopra S, Patil GV, Motwani SK. Release modulating hydrophilic matrix systems of losartan potassium: optimization of formulation using statistical experimental design. Eur J Pharm Biopharm 2007;66:73–82
  • Bejugam NK, Parish HJ, Shankar GN. Influence of formulation factors on tablet formulations with liquid permeation enhancer using factorial design. AAPS PharmSciTech 2009;10:1437–43
  • Singh B, Kapil R, Nandi M, Ahuja N. Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects. Expert Opin Drug Deliv 2011;8:1341–60
  • Landin M, Rowe RC, York P. Advantages of neurofuzzy logic against conventional experimental design and statistical analysis in studying and developing direct compression formulations. Eur J Pharm Sci 2009;38:325–31
  • Carr RL. Evaluating flow properties of solids. Chem Eng 1965;72:163–8
  • USP36–NF31. Chapter 1174: Powder flow. Rockville (MD): USP36–NF31 ed.; 2013:891
  • Yu W, Muteki K, Zhang L, Kim G. Prediction of bulk powder flow performance using comprehensive particle size and particle shape distributions. J Pharm Sci 2011;100:284–93

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.